Porphomethene inhibitor of uroporphyrinogen decarboxylase: Analysis by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry

Biomedical Chromatography

Volumn 21, Issue 7, 2007, Pages 661-663

  Danton, Malcolm ^a   Lim, Chang Kee ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Poly(ethylene glycol); Product ion; Uroporphomethene; Uroporphyrin; Uroporphyrinogen decarboxylase inhibition

Indexed keywords

ETHYLENE GLYCOL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; POLYOLS; PROPIONIC ACID;

DECARBOXYLASES; FRAGMENTATIONS PATTERN; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY; POLY ETHYLENE GLYCOLS; POLY(ETHYLENE GLYCOL); PRODUCT IONS; UROPORPHOMETHENE; UROPORPHYRIN; UROPORPHYRINOGEN DECARBOXYLASE INHIBITION;

POLYETHYLENE GLYCOLS;

ACETIC ACID; MACROGOL; PROPIONIC ACID; TETRAPYRROLE DERIVATIVE; UNCLASSIFIED DRUG; UROPORPHOMETHENE; UROPORPHYRIN; UROPORPHYRINOGEN; UROPORPHYRINOGEN DECARBOXYLASE;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; FRAGMENTATION REACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHOTOOXIDATION;

EID: 34447500583     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.860     Document Type: Article

References (11)

1. Cantoni L, dal Fiume D, Rizzardini M and Ruggieri R. In vitro inhibitory effect on porphyrinogen decarboxylase of liver extract from TCDD treated mice. Toxicology Letter 1984; 20: 211-217.
2. Danton M and Lim CK. Porphyrin profiles in blood, urine and faeces by HPLC/electrospray ionization tandem mass spectrometry. Biomedical Chromatography 2006; 20: 612-621.
3. Danton M and Lim CK. High-performance liquid chromatography/ electrospray ionization tandem mass spectrometry of hydroxylated uroporphyrin and urochlorin derivatives formed by photochemical oxidation of uroporphyrinogen I. Biomedical Chromatography 2007; 21: 534-545.
4. Elder GH. Porphyria cutanea tarda and related disorders. In: The Porphyrin Handbook. Medical Aspects of Porphyrins, Vol. 14, Kadish KM, Smith KM and Guilard R (eds). Academic Press: San Diego, CA, 2003; 67-92.
5. Francis JE and Smith AG. Oxidation of uroporphyrinogens by hydroxyl radicals. Evidence for nonporphyrin products as potential inhibitors of uroporphyrinogen decarboxylase. FEBS Letters 1988; 233: 311-314.
6. Franklin MR, Phillips JD and Kushner JP. Uroporphyria and uroporphyrinogen decarboxylase deficient mouse: interplay with siderosis and polychlorinated biphenyl exposure. Hepatology 2002; 36: 805-811.
7. Lambrecht RW, Jacobs JM, Sinclair PR and Sinclair JF. Inhibition of uroporphyrinogen decarboxylase activity. The role of cytochrome P-450-mediated uroporphyrinogen oxidation. Biochemical Journal 1990; 269: 437-441.
8. Lim CK, Danton M, Clothier B and Smith AG. Dihydroxy-, hydroxyspirolactone-, and dihydroxyspirolactone-urochlorins induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in liver of mice. Chemical Research in Toxicology 2006; 19: 1660-1667.
9. Lin W and Timkovich R. Oxygenated tetrapyrroles produced from porphyrinogens. Bioorganic Chemistry 1994; 22: 72-94.
10. Phillips JD, Bergonia HA, Reilly CA, Franklin, MR and Kushner JP. A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda. Proceedings of the National Academy of Sciences of the United States of America 2007: 104: 5079-5084.
11. Smith AG and Francis JE. Chemically-induced formation of an inhibitor of hepatic uroporphyrinogen decarboxylase in inbred mice with iron overload. Biochemical Journal 1987; 246: 221-226.